Acquisition Corp. Avista serves as Executive at Organogenesis Holdings Inc., where they oversee executive responsibilities. Since joining the company, Acquisition Corp. Avista has executed 8 insider transactions totaling $4.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 14, 2021 involved transacting 21,154,526 shares valued at $0.
Acquisition Corp. Avista currently holds 7,721,298 shares of Organogenesis Holdings Inc. (ORGO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Acquisition Corp. Avista has been a net buyer of ORGO stock. They have purchased $4.9M and sold $0 worth of shares.
Acquisition Corp. Avista's most recent insider trade was on May 14, 2021, when they sold 21,154,526 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.98 |
| Discretionary |
| Mar 13, 2020 | ORGO | $581.9K | Purchase | 135,000 | $4.31 | Discretionary |
| Mar 12, 2020 | ORGO | $589.9K | Purchase | 141,462 | $4.17 | Discretionary |
| Mar 12, 2020 | ORGO | $691.0K | Purchase | 190,887 | $3.62 | Discretionary |
| Sep 10, 2019 | ORGO | $62.2K | Purchase | 12,000 | $5.18 | Discretionary |
| Sep 9, 2019 | ORGO | $128.0K | Purchase | 25,000 | $5.12 | Discretionary |
| Sep 6, 2019 | ORGO | $2.6M | Purchase | 500,000 | $5.18 | Discretionary |